bryophyllum

Botanicalexperimental

Bryophyllum is a group of plant species of the family Crassulaceae native to Madagascar. It is a section or subgenus within the genus Kalanchoe, and was formerly placed at the level of genus. This section is notable for vegetatively growing small plantlets on the fringes of the leaves; these eventually drop off and root. These plantlets arise from mitosis of meristematic-type tissue in notches in the leaves. — Wikipedia

Clinical trial activity

9 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
3

Earliest trial started Jul 1, 2004 (NCT00163579)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • bryophyllum

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06908044Phase 4Jan 1, 2025University of Zurich
NCT06987084Early Phase 1 (Phase 1)Nov 7, 2024McGill University
NCT05110599Phase 2Nov 30, 2021University of Zurich
NCT04825171Phase 4Aug 31, 2021Klinik Arlesheim
NCT04480658N/AJan 1, 2018University of Zurich
NCT02129816Phase 2/Phase 3 (Phase 3)May 1, 2014University of Zurich
NCT01127126Phase 2Dec 1, 2010University of Zurich
NCT00391339Phase 2/Phase 3 (Phase 3)Nov 1, 2006University of Zurich, Weleda AG
NCT00163579Phase 4Jul 1, 2004University of Basel
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of ZurichAcademic/Hospital6542006
Klinik ArlesheimAcademic/Hospital1112021
McGill UniversityAcademic/Hospital1112024
University of BaselAcademic/Hospital1112004
Weleda AGFor profit1112006
5 organizations
Page 1 / 1